Literature DB >> 3712610

Treatment of carcinoma of the penis: the case for primary lymphadenectomy.

W S McDougal, F K Kirchner, R H Edwards, L T Killion.   

Abstract

There were 65 patients with squamous cell carcinoma of the penis followed for a minimum of 5 years. Patients with stage I disease uniformly survived with local treatment only. Of the patients with stages II and III carcinoma of the penis 88 and 66 per cent, respectively, were free of disease if lymphadenectomy was performed shortly following treatment of the primary lesion, compared to only 38 and 0 per cent, respectively, if the primary lesion was treated locally and no lymphadenectomy was performed. These data support the concept that lymphadenectomy should be an integral part of the primary treatment in patients with stages II and III penile cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3712610     DOI: 10.1016/s0022-5347(17)44718-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

Review 1.  [The significance of inguinal lymphadenectomy in carcinoma of the penis].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

2.  Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes.

Authors:  E Hungerhuber; B Schlenker; D Frimberger; R Linke; A Karl; C G Stief; P Schneede
Journal:  World J Urol       Date:  2006-04-11       Impact factor: 4.226

Review 3.  Penile preserving and reconstructive surgery in the management of penile cancer.

Authors:  Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

4.  Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.

Authors:  Shreyas S Joshi; Elizabeth Handorf; David Strauss; Andres F Correa; Alexander Kutikov; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Robert G Uzzo; Marc C Smaldone; Daniel M Geynisman
Journal:  JAMA Oncol       Date:  2018-05-01       Impact factor: 31.777

5.  Neoadjuvant therapy combined with a BMP regimen for treating penile cancer patients with lymph node metastasis: a retrospective study in China.

Authors:  Benkui Zou; Zengchi Han; Zhendan Wang; Jiasheng Bian; Jian Xu; Huansheng Wang; Mingshan Yang; Fajun Pei; Sheng Li; Zhonghua Xu
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-07       Impact factor: 4.553

6.  What next? Managing lymph nodes in men with penile cancer.

Authors:  Michael Leveridge; D Robert Siemens; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

Review 7.  Current trends in the management of carcinoma penis--a review.

Authors:  Iqbal Singh; A Khaitan
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

8.  Extra-anatomical transobturator bypass graft for femoral artery involvement by metastatic carcinoma of the penis: report of five patients.

Authors:  Ubirajara Ferreira; Leonardo Oliveira Reis; Lia Yumi Ikari; Walter da Silva; Wagner Eduardo Matheus; Fernandes Denardi; Rafael Mamprim Stopiglia; Fábio Husseman Menezes
Journal:  World J Urol       Date:  2008-06-26       Impact factor: 4.226

9.  Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis.

Authors:  Vincenzo Ficarra; Guido Martignoni; Nicola Maffei; Maria Angela Cerruto; Giacomo Novara; Stefano Cavalleri; Walter Artibani
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

10.  The importance of microvessel density in predicting cancer progression in patients with penile squamous cell carcinoma.

Authors:  Aditi Arora; Ankur Bansal
Journal:  Int Urol Nephrol       Date:  2017-03-13       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.